Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination With Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vaginal Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02595879
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.066017+00:00
Published At
2024-10-16T00:00:00+00:00
Record Updated At
2025-11-13
Results Posted At
2024-10-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Cervical Adenocarcinoma", "Advanced Cervical Adenosquamous Carcinoma", "Advanced Cervical Squamous Cell Carcinoma", "Advanced Vaginal Adenocarcinoma", "Advanced Vaginal Adenosquamous Carcinoma", "Advanced Vaginal Squamous Cell Carcinoma", "Stage IB2 Cervical Cancer AJCC v6 and v7", "Stage II Cervical Cancer AJCC v7", "Stage II Vaginal Cancer AJCC v6 and v7", "Stage III Vaginal Cancer AJCC v6 and v7", "Stage IIIB Cervical Cancer AJCC v6 and v7", "Stage IVA Cervical Cancer AJCC v6 and v7", "Stage IVA Vaginal Cancer AJCC v6 and v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-13"
protocolSection.identificationModule.nctId
"NCT02595879"
protocolSection.identificationModule.officialTitle
"Phase I Dose-Escalation Bioavailability Study of Oral Triapine in Combination With Concurrent Chemoradiation for Locally Advanced Cervical Cancer (LACC) and Vaginal Cancer"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-10-16"

Study condition terms

  • Advanced Cervical Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Cervical Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Cervical Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Vaginal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Vaginal Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Vaginal Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IB2 Cervical Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage II Cervical Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage II Vaginal Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Vaginal Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Cervical Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Vaginal Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.